Derrick Butler
Family Medicine · Los Angeles, CANPI 1366487225
Payments from drug & device makers
Across 947 payments — averaging $730.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$442K
- Gilead$178K
- Janssen Products, LP$54K
- Viiv Healthcare Company$16K
- Theratechnologies Inc.$750
- Johnson & Johnson$312
- plus $1K from 10 others
What the payments were for
- Consulting fees$20,2253%
- Speaking & faculty fees$517,86475%
- Travel & lodging$130,80219%
- Food & beverage$22,7193%
- Education$1260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 424 | $441,554 |
| Gilead | 315 | $177,694 |
| Janssen Products, LP | 65 | $54,246 |
| Viiv Healthcare Company | 88 | $16,110 |
| Theratechnologies Inc. | 1 | $750 |
| Johnson & Johnson(2 entities) | 16 | $312 |
| Novo Nordisk | 3 | $246 |
| Napo Pharmaceuticals Inc | 12 | $211 |
| AbbVie | 2 | $160 |
| Merck | 8 | $137 |
| Indivior Inc. | 5 | $120 |
| Janssen Scientific Affairs, LLC | 3 | $81 |
| EMD Serono, Inc. | 2 | $50 |
| Alkermes, Inc. | 1 | $30 |
| Mannkind Corporation | 1 | $18 |
| Bayer | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$691,736 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 94 | $363,129 |
| DovatoDolutegravir Sodium/Lamivudine | 91 | $261,109 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 47 | $215,290 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 28 | $96,869 |
| TivicayDolutegravir Sodium | 32 | $69,182 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 13 | $45,773 |
| PrezcobixDarunavir/Cobicistat | 13 | $30,961 |
| OzempicSemaglutide | 27 | $24,280 |
| Maraviroc | 12 | $15,409 |
| EliquisApixaban | 13 | $11,260 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $10,833 |
| Atrovent HfaIpratropium Bromide | 11 | $5,819 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $5,562 |
| Spiriva HandihalerTiotropium Bromide | 11 | $5,517 |
| LumiganBimatoprost | 19 | $5,215 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya | $177,694 | $408,902107 claims |
| Viiv Healthcare CompanyDovato, Tivicay | $16,110 | $330,291123 claims |
| Janssen Products, LPSymtuza | $54,246 | $215,29047 claims |
| Johnson & JohnsonPrezcobix | $312 | $30,96113 claims |
| Novo NordiskOzempic | $246 | $24,28027 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $441,554 | $19,35743 claims |
| AbbVieLumigan | $160 | $5,21519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,533 family medicine providers in California.
Other family medicine in Los Angeles
- Albert NassirLos Angeles$5.7M
- Nader SobhLos Angeles$4.1M
- Alexander RivkinLos Angeles$2.8M
- Pamela KushnerLos Angeles$1.2M
- Scott HowellLos Angeles$793K
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.